Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2018 Dec 20

PMID 30566567

Citations 206

Authors

Timothy M Uyeki

Henry H Bernstein

John S Bradley

Janet A Englund

Thomas M File

Alicia M Fry

Stefan Gravenstein

Frederick G Hayden

Scott A Harper

Jon Mark Hirshon

Michael G Ison

B Lynn Johnston

Shandra L Knight

Allison McGeer

Laura E Riley

Cameron R Wolfe

Paul E Alexander

Andrew T Pavia

Affiliations

Soon will be listed here.

Abstract

These clinical practice guidelines are an update of the guidelines published by the Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza pandemic. This document addresses new information regarding diagnostic testing, treatment and chemoprophylaxis with antiviral medications, and issues related to institutional outbreak management for seasonal influenza. It is intended for use by primary care clinicians, obstetricians, emergency medicine providers, hospitalists, laboratorians, and infectious disease specialists, as well as other clinicians managing patients with suspected or laboratory-confirmed influenza. The guidelines consider the care of children and adults, including special populations such as pregnant and postpartum women and immunocompromised patients.

Citing Articles

Optimizing epidemic prevention in nursing homes using clinical surveillance of respiratory infections.

Gaspard P, Martinot M Infect Prev Pract. 2025; 7(1):100444.

PMID: 40034473 PMC: 11874540. DOI: 10.1016/j.infpip.2025.100444.

Practical Recommendations in the Treatment of Acute and Chronic Life-Threatening Infectious Diseases in Patients with Acute Hepatic Porphyria.

Badia B, Serrano P, Barile J, Seneor D, Mendes P, Cavalheiro R Metabolites. 2025; 15(2).

PMID: 39997724 PMC: 11857646. DOI: 10.3390/metabo15020099.

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.

Shime N, Nakada T, Yatabe T, Yamakawa K, Aoki Y, Inoue S Acute Med Surg. 2025; 12(1):e70037.

PMID: 39996161 PMC: 11848044. DOI: 10.1002/ams2.70037.

Uncovering the Mechanisms of BaBaoWuDanYaoMo Against Influenza A Virus and Virus-Induced Inflammation Based on Network Pharmacology and Pharmacological Evaluation.

Lei B, Su Y, Chen R, Chen Z, Liu B, Chen Y Infect Drug Resist. 2025; 18:567-587.

PMID: 39902273 PMC: 11789520. DOI: 10.2147/IDR.S491101.

Comparative Evaluation of Three Rapid Influenza Diagnostic Tests for Detection of Influenza A and B Viruses Using RT-PCR as Reference Method.

Yin H, Wu W, Lv Y, Kou H, Sun Y J Med Virol. 2025; 97(1):e70162.

PMID: 39812072 PMC: 11733857. DOI: 10.1002/jmv.70162.

References

. Recommendations for Prevention and Control of Influenza in Children, 2018-2019. Pediatrics. 2018; 142(4). DOI: 10.1542/peds.2018-2367. View

Eriksson C, Graham D, Uyeki T, Randolph A . Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*. Pediatr Crit Care Med. 2012; 13(6):625-31. PMC: 6615726. DOI: 10.1097/PCC.0b013e318260114e. View

Gubareva L, Matrosovich M, Brenner M, Bethell R, Webster R . Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis. 1998; 178(5):1257-62. DOI: 10.1086/314440. View

Metersky M, Masterton R, Lode H, File Jr T, Babinchak T . Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012; 16(5):e321-31. DOI: 10.1016/j.ijid.2012.01.003. View

Escuret V, Collins P, Casalegno J, Vachieri S, Cattle N, Ferraris O . A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses. J Infect Dis. 2014; 210(8):1260-9. PMC: 4176448. DOI: 10.1093/infdis/jiu244. View

Memoli M, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K . The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2013; 58(2):214-24. PMC: 3871797. DOI: 10.1093/cid/cit725. View

van der Sande M, Meijer A, Sen-Kerpiclik F, Enserink R, Cools H, Overduin P . Effectiveness of post-exposition prophylaxis with oseltamivir in nursing homes: a randomised controlled trial over four seasons. Emerg Themes Epidemiol. 2014; 11:13. PMC: 4159638. DOI: 10.1186/1742-7622-11-13. View

Gooskens J, Swaan C, Claas E, Kroes A . Rapid molecular detection of influenza outbreaks in nursing homes. J Clin Virol. 2007; 41(1):7-12. DOI: 10.1016/j.jcv.2007.10.023. View

Abe M, Higuchi T, Okada K, Kaizu K, Matsumoto K . Clinical study of influenza-associated rhabdomyolysis with acute renal failure. Clin Nephrol. 2006; 66(3):166-70. DOI: 10.5414/cnp66166. View

10.

Falsey A, Murata Y, Walsh E . Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007; 167(4):354-60. DOI: 10.1001/archinte.167.4.ioi60207. View

11.

Speers D, Williams S, Pinder M, Moody H, Hurt A, Smith D . Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Med J Aust. 2010; 192(3):166-8. DOI: 10.5694/j.1326-5377.2010.tb03459.x. View

12.

Mahony A, Cheng A, Olsen K, Aboltins C, Black J, Johnson P . Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning. Influenza Other Respir Viruses. 2012; 7(3):403-9. PMC: 5779837. DOI: 10.1111/j.1750-2659.2012.00398.x. View

13.

Heneghan C, Onakpoya I, Thompson M, Spencer E, Jones M, Jefferson T . Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014; 348:g2547. PMC: 3981976. DOI: 10.1136/bmj.g2547. View

14.

Bell J, Bonner A, Cohen D, Birkhahn R, Yogev R, Triner W . Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol. 2014; 61(1):81-6. DOI: 10.1016/j.jcv.2014.06.001. View

15.

Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

16.

Blyth C, Iredell J, Dwyer D . Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 361(25):2493. DOI: 10.1056/NEJMc0909049. View

17.

Lee C, Lee J, Kim C . Time-dependent sensitivity of a rapid antigen test in patients with 2009 H1N1 influenza. J Clin Microbiol. 2011; 49(4):1702. PMC: 3122875. DOI: 10.1128/JCM.02247-10. View

18.

Jefferson T, Jones M, Doshi P, Del Mar C . Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ. 2009; 339:b5106. PMC: 2790574. DOI: 10.1136/bmj.b5106. View

19.

Dapat C, Kondo H, Dapat I, Baranovich T, Suzuki Y, Shobugawa Y . Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan. Antiviral Res. 2013; 99(3):261-9. DOI: 10.1016/j.antiviral.2013.06.003. View

20.

Yang S, Cao B, Liang L, Li X, Xiao Y, Cao Z . Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus. PLoS One. 2012; 7(1):e29652. PMC: 3262784. DOI: 10.1371/journal.pone.0029652. View